Endovascular graft

Information

  • Patent Grant
  • 10548750
  • Patent Number
    10,548,750
  • Date Filed
    Friday, August 25, 2017
    6 years ago
  • Date Issued
    Tuesday, February 4, 2020
    4 years ago
Abstract
An endovascular graft, which is configured to conform to the morphology of a vessel to be treated, includes a tubular ePTFE structure; an inflatable ePTFE structure disposed over at least a portion of the ePTFE tubular structure; and an injection port in fluid communication with the inflatable ePTFE structure for inflation of the inflatable ePTFE structure with an inflation medium. The inflatable ePTFE structure may be longitudinally disposed over the tubular ePTFE structure. The ePTFE structure may be a bifurcated structure having first and second bifurcated tubular structures, where the inflatable ePTFE structure is disposed over at least a portion of the first and second bifurcated tubular structures.
Description
BACKGROUND OF THE INVENTION

The present invention relates to a system and method for the treatment of disorders of the vasculature. More specifically, a system and method for treatment of abdominal aortic aneurysm and the like, which is a condition manifested by expansion and weakening of the aorta below the diaphragm. Such conditions require intervention due to the severity of the sequelae, which frequently is death. Prior methods of treating aortic aneurysm have consisted of invasive surgical methods with graft placement within the aorta as a reinforcing member of the artery. However, such a procedure requires a surgical cut down to access the vessel, which in turn can result in a catastrophic rupture of the aneurysm due to the decreased external pressure from the organs and tissues surrounding the aorta, which are moved during the procedure to gain access to the vessel. Accordingly, surgical procedures have a high mortality rate due to the possibility of the rupture discussed above in addition to other factors. Other factors can include poor physical condition of the patient due to blood loss, anuria, and low blood pressure associated with the aortic abdominal aneurysm. An example of a surgical procedure is described in a book entitled Surgical Treatment of Aortic Aneurysms by Denton A. Cooley, M.D., published in 1986 by W.B. Saunders Company.


Due to the inherent risks and complexities of surgical procedures, various attempts have been made in the development of alternative methods for deployment of grafts within aortic aneurysms. One such method is the non-invasive technique of percutaneous delivery by a catheter-based system. Such a method is described in Lawrence, Jr. et al. in “Percutaneous endovascular graft: experimental evaluation”, Radiology (May 1987). Lawrence described therein the use of a Gianturco stent as disclosed in U.S. Pat. No. 4,580,568. The stent is used to position a Dacron fabric graft within the vessel. The Dacron graft is compressed within the catheter and then deployed within the vessel to be treated. A similar procedure has also been described by Mirich et al. in “Percutaneously placed endovascular grafts for aortic aneurysms: feasibility study,” Radiology (March 1989). Mirich describes therein a self-expanding metallic structure covered by a nylon fabric, with said structure being anchored by barbs at the proximal and distal ends.


One of the primary deficiencies of the existing percutaneous devices and methods has been that the grafts and the delivery catheters used to deliver the grafts are relatively large in profile, often up to 24 French and greater, and stiff in bending. The large profile and bending stiffness makes delivery through the irregular and tortuous arteries of diseased vessels difficult and risky. In particular, the iliac arteries are often too narrow or irregular for the passage of a percutaneous device. Because of this, non-invasive percutaneous graft delivery for treatment of aortic aneurysm is not available to many patients who would benefit from it.


Another contraindication for current percutaneous grafting methods and devices is a vessel treatment site with high neck angulation which precludes a proper fit between the graft and the vessel wall. An improper fit or seal between the graft and the vessel wall can result in leaks or areas of high stress imposed upon the diseased vessel which lead to reduced graft efficacy and possibly rupture of the aneurysm.


While the above methods have shown some promise with regard to treating abdominal aortic aneurysms with non-invasive methods, there remains a need for an endovascular graft system which can be deployed percutaneously in a small diameter flexible catheter system. In addition, there is a need for a graft which conforms more closely to the contours of an aortic aneurysm which are often quite irregular and angulated and vary from patient to patient. The present invention satisfies these and other needs.


SUMMARY OF THE INVENTION

The present invention is directed generally to an endovascular graft for vascular treatment and a method for manufacturing and using the graft. The graft generally has an inflatable tubular frame structure which can be configured to conform to the morphology of a patient's vessel to be treated. The frame structure has a proximal end and a distal end with an inflatable cuff disposed on at least one end and preferably both. The inflatable cuffs can be reduced in diameter and profile when deflated for introduction into a patient's vasculature by a catheter based delivery system or other suitable means. The inflatable cuffs provide a sufficiently rigid structure when inflated which supports the graft and seals the graft against the interior surface of the vessel in which it is being deployed. One or more elongated inflatable channels may also be disposed on the graft. Preferably, the elongated channel is disposed between and in fluid communication with a proximal and distal inflatable cuff. The channel provides the desired stiffness upon inflation, prevents kinking of the graft frame, and facilitates deployment of the graft within a patient's body passageway. The elongated inflatable channel can be in a longitudinal or linear configuration with respect to the graft, but is preferably shaped as a helix disposed about the graft. Other orientations such as interconnecting grids or rings may also be suitable for the elongated channels. The inflatable cuffs and the elongated channel contain fluid tight chambers which are generally in fluid communication with each other but which may also be separated by valves or rupture discs therein to selectively control the sequence of inflation or deployment. The fluid tight chambers are typically accessed by an injection port which is configured to accept a pressurized source of gas, fluid, particles, gel or combination thereof and which is in fluid particle, gel or combination thereof and which is a fluid communication with at least one of the fluid tight chambers. A fluid which sets, hardens or gels over time can also be used. The number of elongated channels can vary with the specific configuration of the graft as adapted to a given indication, but generally, the number of channels ranges from 1 to 25, preferably 2 to about 8.


A proximal neck portion may be secured to the proximal inflatable cuff. The proximal neck portion has a flexible tubular structure that has a diameter similar to the proximal inflatable cuff. The proximal neck portion can be configured as a straight tubular section or can be tapered distally or proximally to an increased or decreased diameter. Preferably, the proximal neck portion is secured and sealed to the proximal inflatable cuff and tapers proximally to an increased diameter so as to engage the inside surface of a vessel wall which provides a sealing function in addition to that of the proximal inflatable cuff. Such a configuration also smoothes the transition for fluid flow from the vessel of a patient to the lumen or channel within the endovascular graft. The proximal neck portion has an inlet axis that preferably has an angular bias with respect to a longitudinal axis of the graft.


Preferably, the graft has a monolithic structure wherein the material that comprises the inflatable cuffs and channels extends between these elements in a thin flexible layer that defines a longitudinal lumen to confine a flow of blood or other fluid therethrough. Such a monolithic structure can be made from a variety of suitable polymers including PVC, polyurethane, polyethylene and fluoropolymers such as TFE, PTFE and ePTFE. Additional stiffness or reinforcement can be added to the graft by the addition of metal or plastic inserts or battens to the graft, which can also facilitate positioning and deployment of the graft prior to inflation of an inflatable portion of the graft.


In another embodiment, the graft has a thin flexible layer disposed over or between a proximal inflatable cuff, a distal inflatable cuff, and an elongated inflatable channel of the frame. The thin flexible layer is made of a material differing from the material of the cuffs or elongated channel. The barrier is shaped so as to form a tubular structure defining a longitudinal lumen or channel to confine a flow of blood therethrough. The flexible barrier may be made of a variety of suitable materials such as DACRON®, NYLON®, or fluoropolymers such as TEFLON® or the like.


An endovascular graft having features of the invention may be made in a tubular configuration of a flexible layer material such as Dacron, Nylon or fluoropolymers as discussed above. The inflatable cuffs and elongated channels are formed separately and bonded thereto. The inflatable cuffs and channels may also be made from the same layer material, i.e., Dacron, Teflon, or Nylon with a fluid impermeable membrane or bladder disposed within the cuff or channel so as to make it fluid tight. To limit permeability, the material in the regions of the cuffs and channels may also be treated with a coating or otherwise be processed by methods such as thermo-mechanical compaction.


In one embodiment of the invention, an expansion member is attached to the proximal end of the frame structure of the graft or to a proximal neck portion of the graft. Expansion members may also be attached to the distal end of the graft. Preferably, the expansion member is made of an expandable ring or linked expandable rings of pseudoelastic shape memory alloy which is self-expanding and helps to mechanically anchor the proximal end of the graft to a body channel to prevent axial displacement of the graft once it is deployed. By having an expansion member which is distinct from the proximal cuff, the sealing function of the cuff, which requires supple conformation to the vessel wall without excessive radial force, can be separated from the anchoring function of the expansion member, which can require significant radial force. This allows each function to be optimized without compromising the function of the other. It also allows the anchoring function which can require more radial force on the vessel wall to be located more proximal from the aneurysm than the cuff, and therefor be positioned in a healthier portion of the vessel which is better able to withstand the radial force required for the anchoring function. In addition, the cuff and expansion members can be separated spatially in a longitudinal direction with the graft in a collapsed state for delivery which allows for a lower more flexible profile for percutaneous delivery. Such a configuration makes a collapsed delivery profile of 12-16 French possible, preferably below 12 French.


The expandable ring or rings of the expansion member may be formed in a continuous loop having a serpentine or zig-zag pattern along a circumference of the loop. Any other similar configuration could be used that would allow radial expansion of the ring. The expansion member may be made of suitable high strength metals such as stainless steel, Nitinol or other shape memory alloys, or other suitable high strength composites or polymers. The expansion member may be made from high memory materials such as Nitinol or low memory materials such as stainless steel depending on the configuration of the endovascular graft, the morphology of the deployment site, and the mode of delivery and deployment of the graft.


The expansion member preferably has an inlet axis which forms an inlet axis angle in relation to a longitudinal axis of the graft. The angled inlet axis allows the graft to better conform to the morphology of a patient's vasculature in patients who have an angulated neck aneurysm morphology. The inlet axis angle can be from about 0 to about 90 degrees, preferably about 20 degrees to about 30 degrees. Some or all of the inlet axis angle can be achieved in a proximal neck portion of the graft, to which the expansion member may be attached. An expansion member or members may also be attached to the distal end of the graft.


In another embodiment of the invention, the graft may be bifurcated at the distal end of a main body portion of the graft and have at least two bifurcated portions with longitudinal lumens in fluid communication with a longitudinal lumen of the main body portion. The first bifurcated portion and second bifurcated portion can be formed from a structure similar to that of a main body portion with optional inflatable cuffs at either the proximal or distal end. One or more elongated channels can be disposed between the inflatable cuffs.


The size and angular orientation of the bifurcated portions can vary, however, they are generally configured to have an outer diameter that is compatible with the inner diameter of a patient's iliac arteries. The bifurcated portions can also be adapted to use in a patient's renal arteries or other suitable indication. The distal ends of the bifurcated portions may also have expansion members attached thereto in order to anchor or expand, or both anchor and expand said distal ends within the body passageway being treated. The expansion members for the distal ends of the bifurcated portions can have similar structure to the expansion member attached to the proximal end or proximal neck portion of the main body portion. The expansion members are preferably made from a shape memory material such as Nitinol.


In bifurcated embodiments of grafts having features of the invention which also have a biased proximal end which forms an inlet axis angle, the direction of the bias or angulation can be important with regard to achieving a proper fit between the graft and the morphology of the deployment site. Generally, the angular bias of the proximal end of the graft, proximal neck portion or proximal expansion member can be in any direction. Preferably, the angular bias is in a direction normal to a plane defined by a longitudinal axis of the main body portion, the first bifurcated portion and the second bifurcated portion.


In another embodiment of the invention, rupture discs or other temporary closures are placed between fluid tight chambers of the inflatable cuffs and elongated channel or channels of the graft and form a seal between the chambers. The rupture discs may be burst or broken if sufficient force or pressure is exerted on one side of a disc or temporary closure. Once the graft is located at the site to be treated within a body passageway of a patient, a pressurized gas, fluid or gel may be injected by an inflation catheter into one of the fluid tight chambers of the graft through an injection port. Injection of a pressurized substance into an inflatable cuff will cause the cuff to take a generally annular shape, although the cuff can conform to the shape of the vessel within which it is deployed, and exert a sufficient radial force outward against the inner surface of the body passageway to be treated in order to provide the desired sealing function.


Multiple rupture discs can be disposed in various locations of the graft and also be configured to rupture at different pressures or burst thresholds to facilitate deployment of the graft within a body passageway. In a particular bifurcated embodiment of the invention, the proximal inflatable cuff of the main body portion may be positioned proximal of a junction between the branch of the abdominal aorta and the iliac arteries of a patient. As the proximal cuff is deployed by injection of an appropriate substance into an injection port in fluid communication with the fluid tight chamber thereof, it will expand radially and become axially and sealingly fixed proximal to the bifurcation of the aorta. A rupture disc is located between the fluid tight chamber of the proximal cuff and the elongated inflatable channels so that the proximal cuff may be substantially deployed before the rupture disc bursts and the elongated channels begin to fill with the injected substance. The elongated channels then fill and become sufficiently rigid and expand to create a longitudinal lumen therein. As pressure is increased within the fluid tight chamber, a rupture disc between the fluid tight chamber of the elongated channels and a fluid tight chamber of the optional distal inflatable cuff or distal manifold of the main body portion will burst and the distal inflatable cuff or manifold will deploy and become pressurized. One of the bifurcated portions of the graft may then be deployed as a rupture disc sealing its fluid tight chamber from the distal inflatable cuff or manifold of the main body portion of the graft bursts as the inflation pressure is increased. Finally, the second bifurcated portion of the graft deploys after a rupture disc sealing its fluid tight chamber from the main body portion bursts.


An inflation catheter which is attached to and in fluid communication with the fluid tight chambers of the graft via an injection port disposed thereon can be decoupled from the injection port after completion of inflation by elevating pressure above a predetermined level. The elevated pressure causes a break in a connection with the injection port by triggering a disconnect mechanism. Alternatively, the inflation catheter can be unscrewed from its connection. The injection port can include a check valve, seal or plug to close off the egress of inflation material once the inflation catheter has been decoupled. The injection port could also be glued or twisted to seal it off.


A graft having features of the invention may also be deployed by percutaneous delivery with a catheter based system which has an inflatable balloon member disposed within expansion members of the graft in a collapsed state. The graft is percutaneously delivered to a desired site. Once the graft is axially positioned, the inflatable member of the balloon may be expanded and the expansion members forced radially against the interior surface of a body channel within which it is disposed. The expansion members may also be self expanding from a constrained configuration once the constraint is removed. After the graft has been positioned by the catheter system, the inflatable cuff or cuffs and elongated channel or channels of the graft are pressurized.


These and other advantages of the invention will become more apparent from the following detailed description of the invention when taken in conjunction with the accompanying exemplary drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a perspective view of an endovascular graft having features of the invention.



FIG. 2 shows a longitudinal cross sectional view of an endovascular graft having a monolithic structure.



FIG. 3 shows an enlarged view of the longitudinal cross sectional view of the endovascular graft of FIG. 2.



FIG. 4 shows a longitudinal cross-sectional view of an endovascular graft having features of the invention.



FIG. 5 shows an enlarged view of a portion of the endovascular graft shown in FIG. 4.



FIG. 6 is a perspective view of a bifurcated endovascular graft having features of the present invention.



FIG. 7 is a transverse cross-sectional view of a bifurcated portion of an endovascular graft taken at 7-7 of FIG. 6.



FIGS. 8A, 8B and 8C depict perspective views of a bifurcated endovascular graft having features of the present invention in various stages of deployment.



FIG. 9A is an enlarged longitudinal cross sectional view of the valve that could be used to maintain inflation of a fluid tight chamber in the endovascular graft token at 9-9 of FIG. 8A.



FIG. 9B is an enlarged longitudinal cross sectional view of an alternative seal that could be used to maintain inflation of a fluid tight chamber in the endovascular graft taken at 9-9 of FIG. 8A.



FIG. 9C is an enlarged longitudinal cross sectional view of an alternative sealing plug that could be used to maintain inflation of fluid tight chamber in the endovascular graft taken at 9-9 of FIG. 8A.



FIG. 10 is an enlarged longitudinal cross sectional view of a rupture disc that could be used to control the inflation sequence of an inflatable endovascular graft taken at 10-10 of FIG. 8C.



FIG. 11 is a plot of inflation pressure of an inflatable endovascular graft with respect to time for an endovascular graft having features of the present invention including rupture discs which are configured to yield at various predetermined pressures.





DETAILED DESCRIPTION OF THE INVENTION


FIG. 1 shows a perspective view of an endovascular graft 10 having features of the present invention and having a proximal end 11 and a distal end 12. The graft is supported by an inflatable frame 13 which has a proximal end 14 and a distal end 15 and is shown in its deployed state. The inflatable frame structure 13 has a proximal inflatable cuff 16 at the proximal end 14 and an optional distal inflatable cuff 17 at the distal end 15. The inflatable cuffs 16 and 17 can be annular in shape when deployed, although the cuffs can confirm to the shape of the vessel within which they are deployed, and can have an outside diameter or cross sectional dimension of about 10 to about 45 mm, preferably about 16 to about 28 mm. There is at least one elongated inflatable channel 18 disposed between the proximal inflatable cuff 16 and the distal inflatable cuff 17. The inflatable frame 13 can be from about 5 to about 30 cm in length, preferably about 10 to about 20 cm in length. Disposed between the proximal inflatable cuff 16, the distal inflatable cuff 17 and the elongated inflatable channel 18 is a thin flexible layer 21 that forms a longitudinal lumen 22 which can confine a flow of fluid therethrough. The thin flexible layer 21 may be made from the same material as the inflatable cuffs 16 and 17 and elongated channel 18 and be integral with the construction of those elements forming a monolithic structure. The thin flexible layer 21 and the materials used to form the frame structure 13 can have a wall thickness of about 0.1 to about 0.5 mm, preferably about 0.15 to about 0.25 mm. The inflatable frame 13 may be constructed from any suitable medical polymer or other material, including fluoropolymers, PVCs, polyurethanes, PET, ePTFE and the like. Preferably the inflatable frame 13 and thin flexible layer 21 are made from ePTFE. A proximal heck portion 23 is attached to the proximal end of the inflatable frame structure 13 and serves as an additional means to seal the graft against the inside of a body passageway, provides a means of biasing a proximal end of the graft 11, and provides a smooth flow transition into longitudinal lumen 22.


An expansion member 24 having a proximal end 25 and a distal end 26 has the distal end secured to the proximal end 14 of the frame 13. The distal end 26 of the expansion member may also be secured to the proximal neck portion 23. The expansion member 24 can be made from expandable rings 27 formed in a zig-zag pattern and connected by links 28. The expansion member 24 is preferably a self-expanding member that expands to contact the inside wall of a body passage upon release from a constrained state. The expansion member 24 may be made from any suitable material that permits expansion from a constrained state, preferably a shape memory alloy such as Nitinol. The expansion member 24 may be configured to self-expand from a constrained state or be configured to expand as a result of an outward radial force applied from within. Other materials suitable for construction of the expansion member 24 include stainless steel, MP35N alloy, shape memory alloys other than Nitinol, fiber composites and the like. The links 28 allow articulation of the expansion member 24 to traverse curvature of a patient's anatomy both during delivery and in situ. The expansion member 24 has a generally cylindrical shape but may also have outwardly directed protuberances 32 that are designed to engage the inside surface of a body passage. The expansion member 24 is generally cylindrical in shape when deployed, although the expansion member can conform to the shape of the vessel within which it is deployed, and can have a length of about 0.5 to about 5 cm, preferably about 1 to about 4 cm. The diameter of the expansion member 24 is typically similar to that of the inflatable cuffs 16 and 17, and can be about 10 to about 35 mm, preferably about 16 to about 28 mm. The high strength material from which the expansion member 24 is made can have a cross sectional dimension of about 0.1 to about 1.5 mm, preferably about 0.25 to about 1 mm.


The graft 10 is generally deployed by inflation of the inflatable frame structure 13 with a pressurized material of solid particles, gas, fluid or gel which can be injected through an injection port 33. The pressurized material may contain a contrast medium which facilitates imaging of the device while being deployed within a patient's body. For example, radiopaque materials such as bismuth, barium, gold, platinum, tantalum or the like may be used in particulate or powder form to facilitate visualization of the graft under fluoroscopy. Fixed radiopaque markers may also be attached or integrally molded into the graft for the same purpose, and may be made from the same radiopaque materials discussed above.



FIG. 2 shows a longitudinal cross sectional view of the endovascular graft shown in FIG. 1. Within the proximal inflatable cuff 16 is a fluid tight chamber 41 which is in fluid communication with a fluid tight chamber 42 of the elongated inflatable channel 18. The fluid tight chamber 42 of the elongated inflatable channel is in fluid communication with a fluid tight chamber 43 within the optional distal inflatable cuff 17. A longitudinal axis 44 of the graft 10 is shown in addition to a proximal inlet axis 45 which forms an inlet axis angle 46 with the longitudinal axis. The angled inlet axis 45 is generally created by the proximal neck portion 23 and provides the graft with a profile which can conform to the morphology of a patient's vasculature. The expansion member 24 has a longitudinal axis 47 which is generally coextensive with the proximal inlet axis 45, but can further bend to conform to local anatomy including neck angulation of a diseased vessel.



FIG. 3 shows an enlarged view of the longitudinal cross sectional view of a portion of the proximal end 11 of the graft 10 shown in FIG. 2. A more detailed view of the fluid tight chamber 41 of the proximal inflatable cuff 16 can be seen as well as a more detailed view of the attachment of the distal end 26 of the expansion member 24 to the proximal neck portion 23. The thin flexible layer 21 can be seen disposed between the proximal inflatable cuff 16 and the elongated inflatable channel 18. The expandable rings 27 of the expansion member 24 are connected by links 28 which can be made from the same material as the expansion member or any other suitable material such as a biocompatible fiber or a metal such as stainless steel or Nitinol.



FIG. 4 is a transverse cross-sectional view of an embodiment of an endovascular graft 51, having features of the invention. The proximal inflatable cuff 52, distal inflatable cuff 53, and elongated inflatable channel 54 are formed by sealingly bonding strips of material 55 over a tubular structure 56. The strips 55 are bonded at the edges 57 so as to form fluid tight chambers 58 therein. If the material of the strips 55 which have been bonded to the tubular structure 56 are of a permeable character, an additional material may be used to coat the inside of the fluid tight chambers in order to make them impermeable to fluids. Alternatively, the material of the strips 55 and the material of the elongated tubular member 56 adjacent thereto may be made impermeable by undergoing further thermal, mechanical, or chemical processing. Preferably, thermo-mechanical compaction would be used to render the fluid tight chambers 58 impermeable to fluids which would be suitable for inflating the graft 51.


The proximal end 61 of the graft 51 has a proximal neck portion 62 which has an inlet axis 63 which forms an inlet axis angle 64 with a longitudinal axis 65 of the graft. The inlet axis angle 64 allows the graft 51 to better conform to morphology of a patient's vascular channels. An expansion member 66 is also located at the proximal end 61 of the graft 51 and is formed of expandable rings 67 held together by links 68. The expansion member 66 has a longitudinal axis 71 which can coincide with the inlet axis 63 of the proximal neck portion 62. The graft 51 has a thin flexible layer 72 which extends from the distal end 73 of the graft 51, to the proximal end of the graft 61, including the proximal neck portion 62. The thin flexible layer 72 forms a longitudinal lumen or channel 74 upon deployment of the graft, which confines a flow of blood or other bodily fluid there through.



FIG. 5 is an enlarged view of the longitudinal cross-sectional view of the endovascular graft of FIG. 4. A more detailed view of the fluid tight chamber 58 of the proximal inflatable cuff and elongated inflatable channel can be seen. The edges of the strips 57 which form the proximal inflatable cuff 52 and the elongated inflatable channel 54 are bonded at the edges by any suitable technique such as the use of adhesives, solvents, or heat. Suitable adhesives would include epoxies and cyanoacrylates or the like. Materials suitable for use as the thin flexible layer 72 or the strips 55 includes Dacron, Nylon, Teflon, and also such materials as PVC, polyethylene, polyurethane and ePTFE.



FIGS. 6 and 7 depict an endovascular graft 81 having features of the invention which has a first bifurcated portion 82 and a second bifurcated portion 83. A main body portion 84 of the graft 81 has a proximal end 85 and a distal end 86 with a proximal neck portion 87 disposed at the proximal end as well as an expansion member 91 which can be formed of expandable rings 92 of a suitable material which have been linked together. At the distal end 86 of the main body portion 84 there is an optional distal inflatable cuff 93 which is connected fluidly to a proximal inflatable cuff 94 by an elongated inflatable channel 95. The distal inflatable cuff 93 may optionally be replaced by a manifold or other suitable structure for fluid connection between the elongated inflatable channel 95 and the first bifurcated portion 82 or the second bifurcated portion 83.


The first bifurcated portion 82 has a proximal end 96 and a distal end 97 with an optional distal inflatable cuff 98 located at the distal end. The distal end of the first bifurcated portion 97 may have an expansion member in conjunction with or in place of the distal inflatable cuff 98. The proximal end 96 of the first bifurcated portion 82 is attached to the distal end 86 of the main body portion 84 of the graft 81. The first bifurcated portion 82 has an optional inflatable elongated channel 101 which fluidly connects the distal inflatable cuff 98 of the first bifurcated portion 82 with the distal inflatable cuff 93 of the main body portion 84. The inflatable elongated channel 101 also provides support for first bifurcated portion 82.


The second bifurcated portion 83 generally has a structure similar to that of the first bifurcated portion 82, with a proximal end 102 and a distal end 103. The distal end 103 has an optional distal inflatable cuff 104. The proximal end 102 of the second bifurcated portion 83 is connected to the distal end 86 of the main body portion 84 of the graft 81. The distal end of the second bifurcated portion 103 may have an expansion member in conjunction with or in place of the distal inflatable cuff 104. The second bifurcated portion 83 has an optional inflatable elongated channel 105 which fluidly connects the distal inflatable cuff 104 of the second bifurcated portion 83 with the distal inflatable cuff 93 of the main body portion 84. The inflatable elongated channel 105 also provides support for the second bifurcated portion 83. The inflatable elongated channel of the first bifurcated portion 101 and inflatable elongated channel of the second bifurcated portion 105 may have a linear configuration as shown, a helical configuration similar to the main body portion 84, or any other suitable configuration. Disposed between the proximal inflatable cuff 94, distal inflatable cuff 93 and elongated inflatable channel 95 of the main body portion 84 of the graft 81 is a thin flexible layer 106 which forms a longitudinal lumen 107 to confine the flow of blood or other bodily fluid therethrough. Disposed between the distal inflatable cuff 98 and the elongated inflatable channel 101 of the first bifurcated portion 82 and the distal inflatable cuff 93 of the main body portion 84 is a first thin flexible layer 108 which forms a. longitudinal lumen 109 which is in fluid communication with the longitudinal lumen 107 of the main body portion 84. The second bifurcated portion may also be formed separate of a main body portion and be joined to the main body portion after percutaneous delivery thereof by docking methods. The first and second bifurcated portions 82 and 83 are generally cylindrical in shape when deployed, although they can conform to the shape of a vessel within which they are deployed, and can have a length from about 1 to about 10 cm. The outside diameter of the distal ends of the first and second bifurcated portions 82 and 83 can be from about 2 to about 30 mm, preferably about 5 to about 20 mm.


A second thin flexible layer 111 is disposed between the distal inflatable cuff 104 and elongated inflatable channel 105 of the second bifurcated portion 83 and the distal inflatable cuff 93 of the main body portion 84. The second thin flexible layer 111 forms a longitudinal lumen 112 which is in fluid communication with the longitudinal lumen 107 of the main body portion 84. The thin flexible layer of the first bifurcated portion surrounds the elongated lumen of the first bifurcated portion. The thin flexible layer of the second bifurcated portion surrounds the elongated lumen of the second bifurcated portion.



FIGS. 8A-8C depict an embodiment of an endovascular graft 121 having features of the invention in various stages of deployment. In FIG. 8A, an inflation catheter 122 is connected to an injection port 123 in a first bifurcated portion 124 of the endovascular graft 121. The injection port 123 is connected to a distal inflatable cuff 125 of the first bifurcated portion 124 and is in fluid communication with a fluid tight chamber 126 therein. The first bifurcated portion 124 and a main body portion 127 have been substantially inflated in FIG. 8A, however, a second bifurcated portion 128 has been prevented from deployment by rupture discs 131 which have been disposed within fluid tight chambers 132 of the elongated inflatable channels 133 of the main body portion 127 which are connected to fluid tight chambers 134 of elongated inflatable channels 135 of the second bifurcated portion 128. In FIG. 8B, the second bifurcated portion 128 has been substantially deployed subsequent to a rupture or bursting of the rupture discs 131 disposed within the fluid tight chambers 132 and 134 of the elongated inflatable channels 133 and 135 which permitted the flow of a pressurized substance therein. FIG. 8C shows the endovascular graft fully deployed and illustrates detachment of a distal end 136 of the inflation catheter 122 from the injection port 123 which is carried out by increasing the pressure within the inflation catheter until a disconnect mechanism 137 is triggered.



FIG. 9A illustrates a longitudinal cross-sectional view taken at 9-9 of FIG. 8A. The one-way inflation valve 141 has an outer wall 142, an inner lumen 143, an annular spring stop 144, an annular ball seal 145, a sealing body 146 and a sealing spring 147. The configuration depicted in FIG. 9A allows for the ingress of an inflation medium in the direction of the arrow 148 while preventing an egress of same once pressure is removed.



FIG. 9B illustrates an alternative one way valve. The one-way inflation valve 149 has an outer wall 149A, an inner lumen 149B, a first reed valve 149C, and a second reed valve 149D which is fluidly sealed with the first reed valve in a relaxed state. The configuration depicted in FIG. 9B allows for the ingress of an inflation medium in the direction of the arrow 149E while preventing an egress of same once pressure is removed.



FIG. 9C illustrates an alternative seal 150. The seal has an outer wall 150A, an inner lumen 150B, a plug 150C and a sealing surface 150D. The plug 150C has a sealing head 150E which sealingly engages the sealing surface 150D by irreversible deployment by application of force to the plug in the direction of the arrow 150F.



FIG. 10 depicts a longitudinal cross-sectional view of a rupture disc 151 taken at 10-10 of FIG. 8C. The rupture disc 151 has a wall member 152 which is sealingly secured to the inside surface 153 of a fluid tight chamber 154. The wall member 152 is configured to fail under pressure prior to the failure of the surrounding wall 155 of the fluid tight chamber 154 under pressure. The rupture disc 151 allows for deployment and inflation of fluid tight chambers other than those which have been sealed by the rupture disc. Once sufficient force or pressure is exerted against the wall 152 of the rupture disc to cause failure, the rupture disc 151 will burst and permit the ingress of an inflation medium and deployment of a portion of an inflatable graft, previously sealed by the rupture disc.



FIG. 11 depicts a graphical representation of inflation pressure 161 versus the time 162 at an injection port of an inflatable graft as depicted in FIGS. 8A-8C during the deployment process. P1 represents the inflation pressure at the injection port prior to the rupturing of any rupture discs in the endovascular graft. P2 represents the pressure required to cause failure or bursting of the weakest rupture disc in the endovascular graft after which a portion of the endovascular graft previously sealed by the weakest rupture disc is inflated and deployed. The pressure then increases over time to P3 which is the pressure level required to cause failure or bursting of a second rupture disc. P4 is the pressure level required for triggering a disconnect mechanism at the distal end of the inflation catheter.


While particular forms of the invention have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.

Claims
  • 1. A bifurcated endovascular graft system comprising: a main tubular body portion of biocompatible material having a proximal end and an opposed distal end, the proximal end comprising a proximal neck portion having an open end; the main body portion further comprising: an inflatable cuff permanently secured to the proximal neck portion of the main tubular body portion proximal to the open end of the proximal neck portion and extending around a circumference of the proximal neck portion; anda non-inflatable expansion member having a generally cylindrical shape secured to a portion of the proximal neck portion of the main tubular body portion between the inflatable cuff and the end of the proximal neck portion;a first tubular bifurcated portion of biocompatible material having opposed open ends and secured at the distal end of the main body portion;a second tubular bifurcated portion of biocompatible material having opposed open ends and secured at the distal end of the main body portion;wherein the first and second tubular bifurcated portions further comprise circumferential inflatable channels; andwherein at least one of the circumferential inflatable channels of the first and second tubular bifurcated portions extends only partially around a circumference of the first and second tubular bifurcated portions.
  • 2. The bifurcated endovascular graft system of claim 1, wherein at least one of the circumferential inflatable channels of the first and second tubular bifurcated portions extends fully around the circumference of the first and second tubular bifurcated portions.
  • 3. The bifurcated endovascular graft system of claim 1, further comprising a longitudinal inflatable channel in fluid communication with the inflatable cuff of the main tubular body portion and with the circumferential inflatable channels of the first and second tubular bifurcated portions.
  • 4. The bifurcated endovascular graft system of claim 1, wherein the biocompatible graft material comprises a polymeric material selected from the group consisting of polyvinylchloride (PVC), polyurethane, polyethylene, polyethylene terephthalate (PET) and fluoropolymer.
  • 5. The bifurcated endovascular graft system of claim 4, wherein the fluoropolymer is selected from the group consisting of polytetrafluoroethylene (PTFE) and expanded polytetrafluoroethylene (ePTFE).
  • 6. The bifurcated endovascular graft system of claim 1, wherein the biocompatible graft material for the main tubular body portion, the first and second tubular bifurcated portions; the inflatable cuff and the circumferential inflatable channels are the same.
  • 7. The bifurcated endovascular graft system of claim 1, wherein the biocompatible graft material for the main tubular body portion, the first and second tubular bifurcated portions; the inflatable cuff and the circumferential inflatable channels are different.
  • 8. The bifurcated endovascular graft system of claim 1, wherein the non-inflatable expansion member is configured to self-expand from a constrained state.
  • 9. The bifurcated endovascular graft system of claim 8, wherein the non-inflatable expansion member comprises a shape memory alloy.
  • 10. The bifurcated endovascular graft system of claim 9, wherein the shape memory alloy comprises nitinol.
  • 11. The bifurcated endovascular graft system of claim 1, wherein the non-inflatable expansion member is configured expand to upon application of an outward radial force.
  • 12. The bifurcated endovascular graft system of claim 1, wherein the first tubular bifurcated portion has a first longitudinal length and the second tubular bifurcated portion has a second longitudinal length which is different from the first longitudinal length.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 14/320,773, filed Jul. 1, 2014, which is a continuation of U.S. application Ser. No. 13/737,351, filed Jan. 9, 2013, now U.S. Pat. No. 8,801,769; which is a continuation of U.S. application Ser. No. 12/566,793, filed Sep. 25, 2009, now U.S. Pat. No. 8,361,136; which is a continuation of U.S. application Ser. No. 11/390,732, filed Mar. 28, 2006, now U.S. Pat. No. 7,615,071; which is a continuation of U.S. application Ser. No. 10/132,754, filed Apr. 24, 2002, now U.S. Pat. No. 7,081,129; which is a continuation of U.S. application Ser. No. 09/133,978, filed Aug. 14, 1998, now U.S. Pat. No. 6,395,019; which claims the benefit of U.S. Provisional Application No. 60/074,112, filed Feb. 9, 1998, the contents of all of which are incorporated herein by reference.

US Referenced Citations (550)
Number Name Date Kind
3540431 Uddin Nov 1970 A
3631854 Fryer Jan 1972 A
3657744 Ersek Apr 1972 A
3814137 Martinez Jun 1974 A
3818511 Goldberg et al. Jun 1974 A
3900027 Keedwell Aug 1975 A
3902198 Rathjen Sep 1975 A
3991767 Miller, Jr. et al. Nov 1976 A
4140126 Choudhury Feb 1979 A
4183102 Guiset Jan 1980 A
4187390 Gore Feb 1980 A
4208745 Okita Jun 1980 A
4214587 Sakura, Jr. Jul 1980 A
4434797 Silander Mar 1984 A
4459252 MacGregor Jul 1984 A
4474630 Planck et al. Oct 1984 A
4497074 Rey et al. Feb 1985 A
4512338 Balko et al. Apr 1985 A
4550447 Seiler, Jr. et al. Nov 1985 A
4552707 How Nov 1985 A
4562596 Komberg Jan 1986 A
4577631 Kreamer Mar 1986 A
4580568 Gianturco Apr 1986 A
4592754 Gupte et al. Jun 1986 A
4617932 Komberg Oct 1986 A
4647416 Seiler, Jr. et al. Mar 1987 A
4655769 Zachariades Apr 1987 A
4655771 Wallsten Apr 1987 A
4665906 Jervis May 1987 A
4705517 DiPisa, Jr. Nov 1987 A
4731073 Robinson Mar 1988 A
4739762 Palmaz Apr 1988 A
4740207 Kreamer Apr 1988 A
4776337 Palmaz Oct 1988 A
4787899 Lazarus Nov 1988 A
4816028 Kapadia et al. Mar 1989 A
4830003 Wolff et al. May 1989 A
4856516 Hillstead Aug 1989 A
4941870 Okada et al. Jul 1990 A
4955899 Della Corna et al. Sep 1990 A
4957669 Primm Sep 1990 A
5019090 Pinchuk May 1991 A
5064435 Porter Nov 1991 A
5100422 Berguer et al. Mar 1992 A
5104399 Lazarus Apr 1992 A
5104400 Berguer et al. Apr 1992 A
5108424 Hoffman, Jr. et al. Apr 1992 A
5116365 Hillstead May 1992 A
5122154 Rhodes Jun 1992 A
5123917 Lee Jun 1992 A
5139480 Hickle et al. Aug 1992 A
5151105 Kwan-Gett Sep 1992 A
5152782 Kowligi et al. Oct 1992 A
5156620 Pigott Oct 1992 A
5171252 Friedland Dec 1992 A
5171262 MacGregor Dec 1992 A
5195984 Schatz Mar 1993 A
5197976 Herweck et al. Mar 1993 A
5207695 Trout, III May 1993 A
5219355 Parodi et al. Jun 1993 A
5226913 Pinchuk Jul 1993 A
5234447 Kaster et al. Aug 1993 A
5275622 Lazarus et al. Jan 1994 A
5282847 Trescony et al. Feb 1994 A
5290305 Inoue Mar 1994 A
5316023 Palmaz et al. May 1994 A
5330528 Lazim Jul 1994 A
5334201 Cowan Aug 1994 A
5344426 Lau et al. Sep 1994 A
5344444 Glastra Sep 1994 A
5354310 Gamic et al. Oct 1994 A
5354329 Whalen Oct 1994 A
5360443 Barone et al. Nov 1994 A
5366504 Andersen et al. Nov 1994 A
5370682 Schmitt Dec 1994 A
5370691 Samson Dec 1994 A
5383892 Cardon et al. Jan 1995 A
5387235 Chuter Feb 1995 A
5397345 Lazarus et al. Mar 1995 A
5397355 Marin et al. Mar 1995 A
5405377 Cragg Apr 1995 A
5405379 Lane Apr 1995 A
5411550 Herweck et al. May 1995 A
5423851 Samuels Jun 1995 A
5443498 Fountaine Aug 1995 A
5447152 Kohsai et al. Sep 1995 A
5456713 Chuter Oct 1995 A
5464419 Glastra Nov 1995 A
5464449 Ryan et al. Nov 1995 A
5476506 Lunn Dec 1995 A
5480423 Ravenscroft et al. Jan 1996 A
5489295 Piplani et al. Feb 1996 A
5507769 Marin et al. Apr 1996 A
5507770 Turk Apr 1996 A
5522880 Barone et al. Jun 1996 A
5522881 Lentz Jun 1996 A
5527353 Schmitt Jun 1996 A
5527355 Ahn Jun 1996 A
5529653 Glastra Jun 1996 A
5534024 Rogers Jul 1996 A
5536274 Neuss Jul 1996 A
5554180 Turk Sep 1996 A
5556426 Popadiuk et al. Sep 1996 A
5562724 Vorwerk et al. Oct 1996 A
5562726 Chuter Oct 1996 A
5562727 Turk et al. Oct 1996 A
5562728 Lazarus et al. Oct 1996 A
5571079 Bello et al. Nov 1996 A
5571171 Barone et al. Nov 1996 A
5571173 Parodi Nov 1996 A
5575817 Martin Nov 1996 A
5578071 Parodi Nov 1996 A
5578072 Barone et al. Nov 1996 A
5591229 Parodi Jan 1997 A
5597378 Jervis Jan 1997 A
5607468 Rogers et al. Mar 1997 A
5607478 Lentz et al. Mar 1997 A
5609624 Kalis Mar 1997 A
5609625 Piplani et al. Mar 1997 A
5609627 Goicoechea et al. Mar 1997 A
5609628 Keranen Mar 1997 A
5624685 Takahashi et al. Apr 1997 A
5628782 Myers et al. May 1997 A
5628783 Quiachon et al. May 1997 A
5628786 Banas et al. May 1997 A
5628788 Pinchuk May 1997 A
5630829 Lauterjung May 1997 A
5632772 Alcime et al. May 1997 A
5632840 Campbell May 1997 A
5639278 Dereume et al. Jun 1997 A
5653746 Schmitt Aug 1997 A
5662675 Polanskyj Stockert Sep 1997 A
5662700 Lazarus Sep 1997 A
5665115 Cragg Sep 1997 A
5665117 Rhodes Sep 1997 A
5667523 Byron et al. Sep 1997 A
5669936 Lazarus Sep 1997 A
5676671 Inoue Oct 1997 A
5676696 Marcade Oct 1997 A
5676697 McDonald Oct 1997 A
5681346 Orth et al. Oct 1997 A
5683449 Marcade Nov 1997 A
5683451 Lenker et al. Nov 1997 A
5683452 Barone et al. Nov 1997 A
5683453 Palmaz Nov 1997 A
5693084 Chuter Dec 1997 A
5693087 Parodi Dec 1997 A
5693088 Lazarus Dec 1997 A
5697968 Rogers et al. Dec 1997 A
5700285 Myers et al. Dec 1997 A
5707378 Ahn et al. Jan 1998 A
5707388 Lauterjung Jan 1998 A
5709701 Parodi Jan 1998 A
5709703 Lukie et al. Jan 1998 A
5713917 Leonhardt et al. Feb 1998 A
5716395 Myers et al. Feb 1998 A
5718159 Thompson Feb 1998 A
5718973 Lewis et al. Feb 1998 A
5720776 Chuter et al. Feb 1998 A
5723004 Dereume et al. Mar 1998 A
5725547 Chuter Mar 1998 A
5725549 Lam Mar 1998 A
5733325 Robinson et al. Mar 1998 A
5735892 Myers et al. Apr 1998 A
5735897 Buirge Apr 1998 A
5741325 Chaikof et al. Apr 1998 A
5747128 Campbell et al. May 1998 A
5749880 Banas et al. May 1998 A
5749920 Quiachon et al. May 1998 A
5755772 Evans et al. May 1998 A
5769882 Fogarty et al. Jun 1998 A
5769885 Quiachon et al. Jun 1998 A
5769887 Brown et al. Jun 1998 A
5780807 Saunders Jul 1998 A
5782904 White et al. Jul 1998 A
5782909 Quiachon et al. Jul 1998 A
5785679 Abolfathi et al. Jul 1998 A
5788626 Thompson Aug 1998 A
5789047 Sasaki et al. Aug 1998 A
5799384 Schwartz et al. Sep 1998 A
5800512 Lentz et al. Sep 1998 A
5800518 Piplani et al. Sep 1998 A
5800524 Borghi Sep 1998 A
5824039 Piplani et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5824044 Quiachon et al. Oct 1998 A
5824058 Ravenscroft et al. Oct 1998 A
5827320 Richter et al. Oct 1998 A
5843158 Lenker et al. Dec 1998 A
5843160 Rhodes Dec 1998 A
5843164 Frantzen et al. Dec 1998 A
5843167 Dwyer et al. Dec 1998 A
5843170 Ahn Dec 1998 A
5855598 Pinchuk Jan 1999 A
5858556 Eckert et al. Jan 1999 A
5871536 Lazarus Feb 1999 A
5871537 Holman et al. Feb 1999 A
5871538 Dereume Feb 1999 A
5873906 Lau et al. Feb 1999 A
5876432 Lau et al. Mar 1999 A
5906641 Thompson et al. May 1999 A
5916264 Von Oepen et al. Jun 1999 A
5925061 Ogi et al. Jul 1999 A
5925075 Myers et al. Jul 1999 A
5926650 Suzuki et al. Jul 1999 A
5931865 Silverman et al. Aug 1999 A
5944750 Tanner et al. Aug 1999 A
5957973 Quiachon et al. Sep 1999 A
5961545 Lentz et al. Oct 1999 A
5961546 Robinson et al. Oct 1999 A
5968090 Ratcliff et al. Oct 1999 A
5972441 Campbell et al. Oct 1999 A
5976179 Inoue Nov 1999 A
5976192 McIntyre et al. Nov 1999 A
5976650 Campbell et al. Nov 1999 A
5984956 Tweden et al. Nov 1999 A
5989287 Yang et al. Nov 1999 A
5993481 Marcade et al. Nov 1999 A
5993489 Lewis et al. Nov 1999 A
5997573 Quijano et al. Dec 1999 A
6001123 Lau Dec 1999 A
6004347 McNamara et al. Dec 1999 A
6004348 Banas et al. Dec 1999 A
6007575 Samuels Dec 1999 A
6015429 Lau et al. Jan 2000 A
6015431 Thornton et al. Jan 2000 A
6017362 Lau Jan 2000 A
6017364 Lazarus Jan 2000 A
6019787 Richard et al. Feb 2000 A
6024763 Lenker et al. Feb 2000 A
6025044 Campbell et al. Feb 2000 A
6027779 Campbell et al. Feb 2000 A
6027811 Campbell et al. Feb 2000 A
6030413 Lazarus Feb 2000 A
6030414 Taheri Feb 2000 A
6030415 Chuter Feb 2000 A
6036702 Bachinski et al. Mar 2000 A
6036723 Anidjar et al. Mar 2000 A
6039755 Edwin et al. Mar 2000 A
6039758 Quichon et al. Mar 2000 A
6042605 Martin et al. Mar 2000 A
6042606 Frantzen Mar 2000 A
6045557 White et al. Apr 2000 A
6051020 Coicoechea et al. Apr 2000 A
6053943 Edwin et al. Apr 2000 A
6059821 Anidjar et al. May 2000 A
6059823 Holman May 2000 A
6063114 Nash et al. May 2000 A
6077296 Shokoohi et al. Jun 2000 A
6077297 Robinson et al. Jun 2000 A
6090128 Douglas Jul 2000 A
6096070 Ragheb et al. Aug 2000 A
6098630 Papazoglou Aug 2000 A
6102918 Kerr Aug 2000 A
6102938 Evans et al. Aug 2000 A
6102940 Robichon et al. Aug 2000 A
6110198 Fogarty et al. Aug 2000 A
6117168 Yang et al. Sep 2000 A
6124523 Banas et al. Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6129756 Kugler et al. Oct 2000 A
6132457 Chobotov Oct 2000 A
6132459 Piplani et al. Oct 2000 A
6139572 Campbell et al. Oct 2000 A
6143015 Nobles Nov 2000 A
6143022 Shull et al. Nov 2000 A
6146416 Andersen et al. Nov 2000 A
6146417 Ischinger Nov 2000 A
6149665 Gabbay Nov 2000 A
6149681 Houser et al. Nov 2000 A
6149682 Frid Nov 2000 A
6152956 Pierce Nov 2000 A
6153292 Bell et al. Nov 2000 A
6156063 Douglas Dec 2000 A
6159237 Alt et al. Dec 2000 A
6159239 Greenhalgh Dec 2000 A
6159565 Campbell et al. Dec 2000 A
6162245 Jayaraman Dec 2000 A
6162246 Barone Dec 2000 A
6165210 Lau et al. Dec 2000 A
6165211 Thompson Dec 2000 A
6165212 Dereume et al. Dec 2000 A
6165213 Goicoechea et al. Dec 2000 A
6165214 Lazarus Dec 2000 A
6168610 Marin et al. Jan 2001 B1
6168620 Kerr Jan 2001 B1
6183504 Inoue Feb 2001 B1
6187036 Shaolian et al. Feb 2001 B1
6193745 Fogarty et al. Feb 2001 B1
6197046 Piplani et al. Mar 2001 B1
6197049 Shaolian et al. Mar 2001 B1
6200339 Leschinsky et al. Mar 2001 B1
6203568 Lombardi et al. Mar 2001 B1
6210422 Douglas Apr 2001 B1
6210434 Quichon et al. Apr 2001 B1
6210435 Piplani et al. Apr 2001 B1
6214039 Banas et al. Apr 2001 B1
6217608 Penn et al. Apr 2001 B1
6221102 Baker et al. Apr 2001 B1
6224609 Ressemann et al. May 2001 B1
6235050 Quiachon et al. May 2001 B1
6238432 Parodi May 2001 B1
6241759 Piplani et al. Jun 2001 B1
6245097 Inoue Jun 2001 B1
6245100 Davila et al. Jun 2001 B1
6245101 Drasler et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6248116 Chevillon et al. Jun 2001 B1
6251132 Ravenscroft et al. Jun 2001 B1
6251133 Richter et al. Jun 2001 B1
6254632 Wu et al. Jul 2001 B1
6261317 Inoue Jul 2001 B1
6264684 Banas et al. Jul 2001 B1
6280466 Kugler et al. Aug 2001 B1
6280467 Leonhardt Aug 2001 B1
6283991 Cox et al. Sep 2001 B1
6287330 Johansson et al. Sep 2001 B1
6287335 Drasler et al. Sep 2001 B1
6293968 Taheri Sep 2001 B1
6293969 Chuter Sep 2001 B1
6296661 Davila et al. Oct 2001 B1
6302891 Nadal Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6302908 Parodi Oct 2001 B1
6306164 Kujawski Oct 2001 B1
6312458 Golds Nov 2001 B1
6312462 McDermott et al. Nov 2001 B1
6315791 Gingras et al. Nov 2001 B1
6319276 Holman et al. Nov 2001 B1
6319278 Quinn Nov 2001 B1
6319279 Shannon et al. Nov 2001 B1
6322587 Quiachon et al. Nov 2001 B1
6325819 Pavcnik et al. Dec 2001 B1
6325823 Horzewski et al. Dec 2001 B1
6328762 Anderson et al. Dec 2001 B1
6331188 Lau et al. Dec 2001 B1
6331190 Shokochi et al. Dec 2001 B1
6331191 Chobotov Dec 2001 B1
6336937 Vonesh et al. Jan 2002 B1
6344044 Fulkerson et al. Feb 2002 B1
6344054 Parodi Feb 2002 B1
6346118 Baker et al. Feb 2002 B1
6352553 van der Burg et al. Mar 2002 B1
6352561 Leopold et al. Mar 2002 B1
6355055 Waksman et al. Mar 2002 B1
6355056 Pnheiro Mar 2002 B1
6355063 Calcote Mar 2002 B1
6357104 Myers Mar 2002 B1
6361637 Martin et al. Mar 2002 B2
6364904 Smith Apr 2002 B1
6368355 Uflacker Apr 2002 B1
6379382 Yang Apr 2002 B1
6383213 Wilson et al. May 2002 B2
6387124 Buscemi et al. May 2002 B1
6395019 Chobotov May 2002 B2
6395022 Piplani et al. May 2002 B1
6398803 Layne et al. Jun 2002 B1
6402779 Colone et al. Jun 2002 B1
6406489 Richter et al. Jun 2002 B1
6409756 Murphy Jun 2002 B1
6409757 Trout et al. Jun 2002 B1
6416535 Lazarus Jul 2002 B1
6416537 Martakos et al. Jul 2002 B1
6416542 Marcade et al. Jul 2002 B1
6423084 St Germain Jul 2002 B1
6423089 Gingras et al. Jul 2002 B1
6423090 Hancock Jul 2002 B1
6425898 Wilson et al. Jul 2002 B1
6428506 Simhambhatla et al. Aug 2002 B1
6428565 Wisselink Aug 2002 B1
6428571 Lentz et al. Aug 2002 B1
6432131 Ravenscroft Aug 2002 B1
6432132 Cottone et al. Aug 2002 B1
6436133 Furst et al. Aug 2002 B1
6436135 Goldfarb Aug 2002 B1
6440165 Richter et al. Aug 2002 B1
6443981 Colone et al. Sep 2002 B1
6451047 McCrea et al. Sep 2002 B2
6451050 Rudakov et al. Sep 2002 B1
6451053 Dehdashtian et al. Sep 2002 B1
6454795 Chuter Sep 2002 B1
6454796 Barkman et al. Sep 2002 B1
6464721 Marcade et al. Oct 2002 B1
6464722 Israel et al. Oct 2002 B2
6471721 Dang Oct 2002 B1
6475236 Roubin et al. Nov 2002 B1
6475238 Fedida Nov 2002 B1
6482166 Fariabi Nov 2002 B1
6482227 Solovay Nov 2002 B1
6485513 Fan Nov 2002 B1
6488701 Nolting et al. Dec 2002 B1
6488705 Schmitt et al. Dec 2002 B2
6491719 Fogary et al. Dec 2002 B1
6494904 Love Dec 2002 B1
6494909 Greenhaigh Dec 2002 B2
6497722 Von Oepen et al. Dec 2002 B1
6497868 Tanahashi Dec 2002 B1
6500203 Thompson et al. Dec 2002 B1
6500204 Igaki Dec 2002 B1
6506211 Skubitz et al. Jan 2003 B1
6508833 Pavcnik et al. Jan 2003 B2
6517571 Brauker et al. Feb 2003 B1
6517574 Chuter Feb 2003 B1
6520984 Garrison et al. Feb 2003 B1
6521284 Parsons et al. Feb 2003 B1
6524334 Thompson Feb 2003 B1
6533811 Ryan et al. Mar 2003 B1
6537202 Frantzen Mar 2003 B1
6540778 Quiachon et al. Apr 2003 B1
6547814 Edwin et al. Apr 2003 B2
6547815 Myers Apr 2003 B2
6551350 Thornton et al. Apr 2003 B1
6554857 Zilla et al. Apr 2003 B1
6554858 Dereume et al. Apr 2003 B2
6558414 Layne May 2003 B2
6582458 White et al. Jun 2003 B1
6599275 Fischer, Jr. Jul 2003 B1
6613082 Yang Sep 2003 B2
6613083 Alt Sep 2003 B2
6613084 Yang Sep 2003 B2
6652570 Smith et al. Nov 2003 B2
6673103 Golds et al. Jan 2004 B1
6685736 White et al. Feb 2004 B1
6689158 White et al. Feb 2004 B1
6689159 Lau et al. Feb 2004 B2
6692523 Holman et al. Feb 2004 B2
6695875 Stelter et al. Feb 2004 B2
6706064 Anson Mar 2004 B1
6709455 Chouinard Mar 2004 B1
6719783 Lentz et al. Apr 2004 B2
6740115 Lombardi May 2004 B2
7615071 Chobotov Nov 2009 B2
8801769 Chobotov Aug 2014 B2
20010002443 Parodi May 2001 A1
20010004705 Killion et al. Jun 2001 A1
20010007955 Drasler et al. Jul 2001 A1
20010010013 Cox et al. Jul 2001 A1
20010011188 Berry et al. Aug 2001 A1
20010014823 Ressemann et al. Aug 2001 A1
20010016770 Allen et al. Aug 2001 A1
20010018610 Limon Aug 2001 A1
20010020184 Dehdashtian et al. Sep 2001 A1
20010023370 Smith et al. Sep 2001 A1
20010027338 Greenberg Oct 2001 A1
20010027339 Boatman et al. Oct 2001 A1
20010029349 Leschinsky Oct 2001 A1
20010029397 Thompson Oct 2001 A1
20010037142 Stelter et al. Nov 2001 A1
20010037146 Lau et al. Nov 2001 A1
20010037147 Lau et al. Nov 2001 A1
20010039446 Edwin et al. Nov 2001 A1
20010041928 Pavenik et al. Nov 2001 A1
20010044652 Moore Nov 2001 A1
20010047198 Drasler et al. Nov 2001 A1
20010049534 Lachat Dec 2001 A1
20010049550 Martin et al. Dec 2001 A1
20010053929 Vonesh et al. Dec 2001 A1
20020002397 Martin et al. Jan 2002 A1
20020007193 Tanner et al. Jan 2002 A1
20020007212 Brown et al. Jan 2002 A1
20020016623 Kula et al. Feb 2002 A1
20020016626 DiMatteo et al. Feb 2002 A1
20020016627 Golds Feb 2002 A1
20020019665 Dehdashtian et al. Feb 2002 A1
20020026231 Shannon et al. Feb 2002 A1
20020026235 Anderson et al. Feb 2002 A1
20020032408 Parker et al. Mar 2002 A1
20020040235 Holman et al. Apr 2002 A1
20020040236 Lau et al. Apr 2002 A1
20020040237 Lentz et al. Apr 2002 A1
20020042644 Greenhalgh Apr 2002 A1
20020042645 Shannon Apr 2002 A1
20020045931 Sogard et al. Apr 2002 A1
20020045933 Jang Apr 2002 A1
20020045934 Jang Apr 2002 A1
20020045935 Jang Apr 2002 A1
20020049487 Lootz et al. Apr 2002 A1
20020049490 Pollock et al. Apr 2002 A1
20020049493 Jang Apr 2002 A1
20020052627 Boylan et al. May 2002 A1
20020052645 Kugler et al. May 2002 A1
20020052649 Greenhalgh May 2002 A1
20020055768 Hess et al. May 2002 A1
20020065552 Jayaraman et al. May 2002 A1
20020072792 Burgermeister et al. Jun 2002 A1
20020082675 Myers Jun 2002 A1
20020091440 Calcote Jul 2002 A1
20020096252 Lukic Jul 2002 A1
20020098278 Bates et al. Jul 2002 A1
20020099434 Buscemi et al. Jul 2002 A1
20020099436 Thornton et al. Jul 2002 A1
20020107561 Pinheiro Aug 2002 A1
20020111633 Stoltze et al. Aug 2002 A1
20020111665 Lauterjung Aug 2002 A1
20020111669 Pazienza et al. Aug 2002 A1
20020116047 Vardi et al. Aug 2002 A1
20020116048 Chobotov Aug 2002 A1
20020116051 Cragg Aug 2002 A1
20020120321 Gunderson et al. Aug 2002 A1
20020120325 Richter et al. Aug 2002 A1
20020120327 Cox et al. Aug 2002 A1
20020123790 White et al. Sep 2002 A1
20020128703 Ravenscroft Sep 2002 A1
20020128706 Osypka Sep 2002 A1
20020133221 Schatz Sep 2002 A1
20020138048 Tuch Sep 2002 A1
20020138126 Camrud et al. Sep 2002 A1
20020138129 Armstrong et al. Sep 2002 A1
20020143381 Gilligan et al. Oct 2002 A1
20020147492 Shokoohi et al. Oct 2002 A1
20020151954 Brenneman Oct 2002 A1
20020156518 Tehrani Oct 2002 A1
20020156521 Ryan et al. Oct 2002 A1
20020156522 Ivancev et al. Oct 2002 A1
20020165602 Douglas et al. Nov 2002 A1
20020165603 Thornton et al. Nov 2002 A1
20020165607 Alt Nov 2002 A1
20020169499 Zilla et al. Nov 2002 A1
20020173836 Pinchuk Nov 2002 A1
20020173837 Lauterjung Nov 2002 A1
20020183825 Solem Dec 2002 A1
20020193871 Beyersdorf et al. Dec 2002 A1
20020193872 Trout et al. Dec 2002 A1
20020193873 Brucker et al. Dec 2002 A1
20020198585 Wisselink Dec 2002 A1
20020198587 Greenberg et al. Dec 2002 A1
20020198588 Armstrong et al. Dec 2002 A1
20030004559 Lentz et al. Jan 2003 A1
20030006528 Edwin et al. Jan 2003 A1
20030009211 DiCarlo Jan 2003 A1
20030009212 Kerr Jan 2003 A1
20030060871 Hill et al. Mar 2003 A1
20030074048 Sherry Apr 2003 A1
20030074050 Kerr Apr 2003 A1
20030074058 Sherry Apr 2003 A1
20030093145 Lawrence-Brown et al. May 2003 A1
20030097170 Friedrich et al. May 2003 A1
20030097174 Henderson May 2003 A1
20030125797 Chobotov et al. Jul 2003 A1
20030143330 Loomis et al. Jul 2003 A1
20030216802 Chobotov Nov 2003 A1
20040024446 Smith Feb 2004 A1
20040049264 Sowinski et al. Mar 2004 A1
20040054397 Smith et al. Mar 2004 A1
20040073190 Deem et al. Apr 2004 A1
20040073287 Goicoechea et al. Apr 2004 A1
20040082989 Cook et al. Apr 2004 A1
20040093068 Bergen et al. May 2004 A1
20040098115 Goicoechea et al. May 2004 A1
20040106978 Greenberg et al. Jun 2004 A1
Foreign Referenced Citations (134)
Number Date Country
0407566 Jan 1990 EP
0480667 Apr 1992 EP
0646151 Jun 1992 EP
0502905 Sep 1992 EP
0541443 May 1993 EP
0617930 May 1994 EP
0646365 Apr 1995 EP
0664107 Jul 1995 EP
0473694 Dec 1995 EP
0473727 Dec 1995 EP
0689806 Jan 1996 EP
0712614 May 1996 EP
0714641 Jun 1996 EP
0747069 Dec 1996 EP
0775472 May 1997 EP
0792627 Sep 1997 EP
0808613 Nov 1997 EP
0809997 Dec 1997 EP
0821979 Feb 1998 EP
0734235 Feb 1999 EP
0814729 Aug 2000 EP
1029518 Aug 2000 EP
0441516 Mar 2001 EP
1093772 Apr 2001 EP
1121945 Aug 2001 EP
0821648 Sep 2001 EP
0808140 Dec 2001 EP
1163889 Dec 2001 EP
1208817 May 2002 EP
1212987 Jun 2002 EP
1212988 Jun 2002 EP
1212989 Jun 2002 EP
1212991 Jun 2002 EP
0877582 Oct 2002 EP
1148843 Apr 2003 EP
0997115 Oct 2003 EP
1380270 Jan 2004 EP
1051135 Mar 2004 EP
1405613 Apr 2004 EP
1415617 Apr 2004 EP
1426020 Jun 2004 EP
5161665 Jun 1993 JP
WO 9008801 Aug 1990 WO
WO 9014055 Nov 1990 WO
WO 910792 Jun 1991 WO
WO 9200043 Jan 1992 WO
WO 9222604 Dec 1992 WO
WO 9313824 Jul 1993 WO
WO 9319804 Oct 1993 WO
WO 9403127 Feb 1994 WO
WO 9503754 Feb 1995 WO
WO 9509585 Apr 1995 WO
WO 9509586 Apr 1995 WO
WO 9511720 May 1995 WO
WO 9516406 Jun 1995 WO
WO 9610967 Apr 1996 WO
WO 9624308 Aug 1996 WO
WO 9628115 Sep 1996 WO
WO 9703624 Feb 1997 WO
WO 9707751 Mar 1997 WO
WO 9725938 Jul 1997 WO
WO 9727820 Aug 1997 WO
WO 9727959 Aug 1997 WO
WO 9729716 Aug 1997 WO
WO 9733533 Sep 1997 WO
WO 9737616 Oct 1997 WO
WO 9741804 Nov 1997 WO
WO 9806355 Feb 1998 WO
WO 9810806 Mar 1998 WO
WO 9812989 Apr 1998 WO
WO 9827894 Jul 1998 WO
WO 9830156 Jul 1998 WO
WO 9833453 Aug 1998 WO
WO 9836708 Aug 1998 WO
WO 9838947 Sep 1998 WO
WO 9841167 Sep 1998 WO
WO 9844870 Oct 1998 WO
WO 9844873 Oct 1998 WO
WO 9855047 Dec 1998 WO
WO 9900073 Jan 1999 WO
WO 9911199 Mar 1999 WO
WO 9932051 Jul 1999 WO
WO 9938455 Aug 1999 WO
WO 9939662 Aug 1999 WO
WO 9939663 Aug 1999 WO
WO 9943378 Sep 1999 WO
WO 9943379 Sep 1999 WO
WO 9947078 Sep 1999 WO
WO 9965419 Dec 1999 WO
WO 0010487 Mar 2000 WO
WO 0019943 May 2000 WO
WO 0033769 Jun 2000 WO
WO 0042947 Jul 2000 WO
WO 0042948 Jul 2000 WO
WO 0045741 Aug 2000 WO
WO 0051522 Sep 2000 WO
WO 0053251 Sep 2000 WO
WO 0101886 Jan 2001 WO
WO 0101887 Jan 2001 WO
WO 0115633 Mar 2001 WO
WO 0121102 Mar 2001 WO
WO 0121107 Mar 2001 WO
WO 0121108 Mar 2001 WO
WO 0128456 Apr 2001 WO
WO 0130270 May 2001 WO
WO 0139700 Jun 2001 WO
WO 0141675 Jun 2001 WO
WO 0152771 Jul 2001 WO
WO 0152914 Jul 2001 WO
WO 0166037 Sep 2001 WO
WO 0166038 Sep 2001 WO
WO 0167993 Sep 2001 WO
WO 0174270 Oct 2001 WO
WO 0236332 May 2002 WO
WO 02087651 Nov 2002 WO
WO 02100454 Dec 2002 WO
WO 03000308 Jan 2003 WO
WO 03003946 Jan 2003 WO
WO 03008005 Jan 2003 WO
WO 03015837 Feb 2003 WO
WO 03026713 Apr 2003 WO
WO 03084440 Oct 2003 WO
WO 03094795 Nov 2003 WO
WO 03094797 Nov 2003 WO
WO 03094799 Nov 2003 WO
WO 04002370 Jan 2004 WO
WO 04004603 Jan 2004 WO
WO 04004966 Jan 2004 WO
WO 04016193 Feb 2004 WO
WO 04017866 Mar 2004 WO
WO 04017867 Mar 2004 WO
WO 04021931 Mar 2004 WO
WO 04037116 May 2004 WO
WO 04045393 Jun 2004 WO
Non-Patent Literature Citations (9)
Entry
US 6,413,270 B1, 07/2002, Thornton et al. (withdrawn)
Haimovitch, L. and Patterson, N., “Robust growth is forecast for endovascular repair fo AAAs,” The BBI Newsletter, vol. 26, No. 5, pp. 113-144, (May 2003).
Blum, et al., “Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms,” N. Engl J. Med, 336(1):13-20, (1997).
Ernst, “Current therapy for infrarenal aortic aneurysms,” N. Engl J Med, 336(1):59-60, (1997).
Moore, et al., “Transfemoral endovascular repair of abdominal aortic aneurysm; results of the North American EVT phase 1 trail,” J Vasc Surg, 23(4):543-553, (1996).
Parodi, “Endovascular repair of abdominal aortic aneurysms and other arterial lesions,” J Vasc Surg, 21(4):549-557, (1995).
Parodi, et al., “Transfemoral intraluminal graft implantation for abdominal aortic aneurysms,” Ann Vasc Surg, 5(6):491-499, (1991).
Uflacker, et al., “Endovascular treatment of abdominal aortic aneurysms: a review,” Eur. Radiol., 11:739-19753 (2001).
European Search Report for EP 09013660.7, dated Dec. 29, 2009.
Related Publications (1)
Number Date Country
20170348125 A1 Dec 2017 US
Provisional Applications (1)
Number Date Country
60074112 Feb 1998 US
Continuations (6)
Number Date Country
Parent 14320773 Jul 2014 US
Child 15686214 US
Parent 13737351 Jan 2013 US
Child 14320773 US
Parent 12566793 Sep 2009 US
Child 13737351 US
Parent 11390732 Mar 2006 US
Child 12566793 US
Parent 10132754 Apr 2002 US
Child 11390732 US
Parent 09133978 Aug 1998 US
Child 10132754 US